4.8 Article

A High-Performance Nanobio Photocatalyst for Targeted Brain Cancer Therapy

期刊

NANO LETTERS
卷 9, 期 9, 页码 3337-3342

出版社

AMER CHEMICAL SOC
DOI: 10.1021/nl901610f

关键词

-

资金

  1. U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]
  2. National Cancer Institute [R01-CA1 22930, R21-CA135728 MSL]
  3. National Institute of Neurological Disorders and Stroke [K08-NS046430]
  4. Alliance for Cancer Gene Therapy Young Investigator Award
  5. American Cancer Society [RSG-07-276-01-MGO]
  6. Brain Research Foundation [FAS 6-33186]
  7. NATIONAL CANCER INSTITUTE [R21CA135728, R01CA122930] Funding Source: NIH RePORTER
  8. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS046430] Funding Source: NIH RePORTER

向作者/读者索取更多资源

We report pronounced and specific antiglioblastoma cell phototoxicity of 5 nm TiO2 particles covalently tethered to an antibody via a dihydroxybenzene bivalent linker. The linker application enables absorption of a visible part of the solar spectrum by the nanobio hybrid. The phototoxicity is mediated by reactive oxygen species (ROS) that initiate programmed death of the cancer cell. Synchrotron X-ray fluorescence microscopy (XFM) was applied for direct visualization of the nanobioconjugate distribution through a single brain cancer cell at the submicrometer scale.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据